Pharmacogenomics of neurodegenerative diseases
Identifieur interne : 001958 ( Main/Exploration ); précédent : 001957; suivant : 001959Pharmacogenomics of neurodegenerative diseases
Auteurs : Davide Maimone [Italie] ; Roberto Dominici [Italie] ; Luigi M. E. Grimaldi [Italie]Source :
- European Journal of Pharmacology [ 0014-2999 ] ; 2000.
Abstract
Current knowledge of sporadic degenerative disorders suggests that, despite their multifactorial etiopathogenesis, genetics plays a primary role in orchestrating the pathological events, and even dramatically changes the disease phenotype from patient to patient. Genes may act as susceptibility factors, increasing the risk of disease development, or may operate as regulatory factors, modulating the magnitude and severity of pathogenic processes or the response to drug treatment. The goal of pharmacogenomics is the application of this knowledge to elaborate more specific and effective treatments and to tailor therapies to individual patients according to their genetic profile. Here, we outline the leading theories on the etiopathogenesis of neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer disease, and we review the potential role of genetic variations, such as gene mutations and polymorphisms, in each context. We also suggest potential targets for new therapeutic approaches and variability factors for current treatments based on genotype features. Finally, we propose a few options of preventive therapeutic interventions in patients with a high genetic risk of disease.
Url:
DOI: 10.1016/S0014-2999(00)00939-0
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Pharmacogenomics of neurodegenerative diseases</title><author><name sortKey="Maimone, Davide" sort="Maimone, Davide" uniqKey="Maimone D" first="Davide" last="Maimone">Davide Maimone</name></author><author><name sortKey="Dominici, Roberto" sort="Dominici, Roberto" uniqKey="Dominici R" first="Roberto" last="Dominici">Roberto Dominici</name></author><author><name sortKey="Grimaldi, Luigi M E" sort="Grimaldi, Luigi M E" uniqKey="Grimaldi L" first="Luigi M. E." last="Grimaldi">Luigi M. E. Grimaldi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:222F0D1D4E59F98394705950B91E32DCABDEBE80</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1016/S0014-2999(00)00939-0</idno><idno type="url">https://api.istex.fr/document/222F0D1D4E59F98394705950B91E32DCABDEBE80/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001A51</idno><idno type="wicri:Area/Main/Curation">001793</idno><idno type="wicri:Area/Main/Exploration">001958</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Pharmacogenomics of neurodegenerative diseases</title><author><name sortKey="Maimone, Davide" sort="Maimone, Davide" uniqKey="Maimone D" first="Davide" last="Maimone">Davide Maimone</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurology, Ospedale Garibaldi, Piazza S. Maria di Gesù 5, 95123 Catania</wicri:regionArea><wicri:noRegion>95123 Catania</wicri:noRegion></affiliation></author><author><name sortKey="Dominici, Roberto" sort="Dominici, Roberto" uniqKey="Dominici R" first="Roberto" last="Dominici">Roberto Dominici</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto Scientifico San Raffaele, Dipartimento di Neuroscienze, Via Olgettina 58, 20132 Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Grimaldi, Luigi M E" sort="Grimaldi, Luigi M E" uniqKey="Grimaldi L" first="Luigi M. E." last="Grimaldi">Luigi M. E. Grimaldi</name><affiliation wicri:level="1"><country wicri:rule="url">Italie</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto Scientifico San Raffaele, Dipartimento di Neuroscienze, Via Olgettina 58, 20132 Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Pharmacology</title><title level="j" type="abbrev">EJP</title><idno type="ISSN">0014-2999</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">413</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="11">11</biblScope><biblScope unit="page" to="29">29</biblScope></imprint><idno type="ISSN">0014-2999</idno></series><idno type="istex">222F0D1D4E59F98394705950B91E32DCABDEBE80</idno><idno type="DOI">10.1016/S0014-2999(00)00939-0</idno><idno type="PII">S0014-2999(00)00939-0</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0014-2999</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Current knowledge of sporadic degenerative disorders suggests that, despite their multifactorial etiopathogenesis, genetics plays a primary role in orchestrating the pathological events, and even dramatically changes the disease phenotype from patient to patient. Genes may act as susceptibility factors, increasing the risk of disease development, or may operate as regulatory factors, modulating the magnitude and severity of pathogenic processes or the response to drug treatment. The goal of pharmacogenomics is the application of this knowledge to elaborate more specific and effective treatments and to tailor therapies to individual patients according to their genetic profile. Here, we outline the leading theories on the etiopathogenesis of neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer disease, and we review the potential role of genetic variations, such as gene mutations and polymorphisms, in each context. We also suggest potential targets for new therapeutic approaches and variability factors for current treatments based on genotype features. Finally, we propose a few options of preventive therapeutic interventions in patients with a high genetic risk of disease.</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Lombardie</li></region><settlement><li>Milan</li></settlement></list><tree><country name="Italie"><noRegion><name sortKey="Maimone, Davide" sort="Maimone, Davide" uniqKey="Maimone D" first="Davide" last="Maimone">Davide Maimone</name></noRegion><name sortKey="Dominici, Roberto" sort="Dominici, Roberto" uniqKey="Dominici R" first="Roberto" last="Dominici">Roberto Dominici</name><name sortKey="Grimaldi, Luigi M E" sort="Grimaldi, Luigi M E" uniqKey="Grimaldi L" first="Luigi M. E." last="Grimaldi">Luigi M. E. Grimaldi</name><name sortKey="Grimaldi, Luigi M E" sort="Grimaldi, Luigi M E" uniqKey="Grimaldi L" first="Luigi M. E." last="Grimaldi">Luigi M. E. Grimaldi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001958 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001958 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:222F0D1D4E59F98394705950B91E32DCABDEBE80
|texte= Pharmacogenomics of neurodegenerative diseases
}}
| This area was generated with Dilib version V0.6.23. |  |